CORONA, Calif., Jan. 16, 2018 -- Acology Inc. (OTC MARKETS:ACOL) reports sharp increases in sales throughout Canada as the country edges towards total legalization later this year. Sales of Acology’s Signature product, the Medtainer™ are far outpacing the market for the same period of time last year. Acology’s FDA compliant multi-functional containers have been sold to and are being used by Canada’s four major licensed producers (LPs) due to its’ ideal assembly and material construction, making it legally compliant for both retail and medical sales. The LPs include the biggest names in the cannabis industry; Aurora, Organigram, Aphria and Tilray. In addition, the MedTainer is also being used by Canadian LPs RedeCan Pharm, James E. Wagner (JWC) and 7Acres. Since the middle of 2017 each MedTainer is also packed and sold with the FDA approved Med-X two-way humidity pack (Powered by Integra Boost - Desiccare). This near-perfect combination extends shelf life and enhances the freshness of cannabis and has been highly praised by consumers. Acology products are now found in stores, dispensaries and medical distributors throughout all of Canada from coast-to-coast.
It is important to note that the Canadian healthcare system has also taken notice of the MedTainer as a packaging and delivery method that is compliant with Canadian federal packaging regulations. There are now many exchanges throughout the country that distribute cannabis solely in MedTainers.
Acology is now centered in 2 of the largest cannabis markets in the world. With long-term planning, which begun in 2013 and has aggressively continued to this day, management is fully prepared to take full advantage of this enviable position. The Medtainer was seen very early as both a state and federally compliant packaging and delivery system. (Attached is the Certificate that was awarded to Acology by the prestigious firm of Child Related Research Inc. in Murray, Utah, for a perfect score in child-resistant packaging) In addition, as 2018 advances Acology also finds itself in excellent position to take advantage of several burgeoning markets, including medical and recreational cannabis, health care, senior care and veterinary care. In addition, their wholly-owned subsidiary, D&C Distributors LLC, efficiently covers more that 25 countries world-wide. Acology’s product lines now include its’ signature product, the Medtainer ™, hydroponic equipment, 2-way humidifiers, collective and retail store products and, soon, CBD products. Customer satisfaction in every aspect of its’ operation, including manufacturing, shipping, marketing, social media, art production and product branding has never been higher, achieving a better than 98.5%.
Acology management has worked diligently to bring the company to this position. 2018 is expected to be an exceptional year for investors and consumers and where, hopefully, the hard work pays off.
For investor or sales information please visit Acology Inc. and D&C Distributors online or by phone. The company is located in their production and distribution facility at 1620 Commerce St. Corona, California, 92880.
Acology trades on the OTC under the call letters ACOL. The company’s websites are www.Acologyinc.com for the hospice and palliative care industry and www.themedtainer.com for the recreational and medical marijuana industry. Orders for Acology products can be taken online and by phone. Custom orders are especially welcome. Please send all inquiries to [email protected] or call (844) ACOLOGY (844-226-5649). Ask for Jack Rein, National Services Director. Acology can also be accessed through Twitter and Instagram at @Acologyinc
This press release includes statements that are covered by the Private Securities Litigation Reform Act of 1995. Because such statements deal with future events they are subject to risks and uncertainties and actual results for fiscal year 2016 and beyond could differ materially from the company’s current expectations. Forward-looking statements are identified by such words as “anticipates”, “projects”, “expects”, “planned”, “intends” and “believes” “estimate” “targets” and other similar expressions that indicate trends and future events. It is understood that investment entails risk on the part of the investor and could result in the loss of some or all his or her investment.
A PDF accompanying this announcement is available at http://resource.globenewswire.com/Resource/Download/ecabce2c-946d-4fa8-b02a-b0920ad29263


Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Anta Sports Expands Global Footprint With Strategic Puma Stake
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Washington Post Publisher Will Lewis Steps Down After Layoffs 



